Research institute
What if you could detect cancer just as it is getting started? New research published in the journal Nature just might give medicine the tools to do just that.
In honor of Black History Month, BioSpace chose to highlight 10 African American leaders in the life sciences, individuals who have prominent roles in the life sciences and biopharmaceutical industry.
The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. With such an enormous global focus, it seems that new information about the virus and the infection is being published each day.
The focus of the research will be to learn more about ApoE4 and how and why it affects Alzheimer’s disease.
Analysis finds that highly innovative drugs took longer to reach NHS patients than more conventional treatments
The UK’s leading dementia research charity, Alzheimer’s Research UK, has awarded Dr Shane Liddelow the prestigious David Hague Early Career Investigator of the Year Award.
Multiple studies point to important role for B cells in promoting anti-tumor immunity
The Institute of Cancer Research, London, has criticised the decision by NICE not to recommend the immunotherapy, pembrolizumab, as a first-line treatment for patients with advanced head and neck cancer and is calling for an urgent reassessment of the evidence for the drug’s benefit.
Aggressive, highly mutated cancers evolve escape routes in response to immune attacks in an ‘evolutionary arms race’ between cancer and the immune system, a new study reports.
The Institute of Cancer Research, London, strongly welcomes the recommendation by the Scottish Medicines Consortium to make the prostate cancer drug abiraterone, when given alongside hormone therapy, available to men with advanced prostate cancer as first-line treatment on the NHS in Scotland.
PRESS RELEASES